US will pay vaccine maker Moderna $176 million to develop an mRNA-based pandemic flu vaccine
US will pay vaccine maker Moderna $176 million to develop an mRNA-based pandemic flu vaccine
WASHINGTON -- US will pay vaccine maker Moderna $176 million to develop an mRNA-based pandemic flu vaccine.